|
| |
| The second trading week of February on the Tel Aviv Stock Exchange (TASE) was marked by a mix trend.
The TA-25 index which almost didn't change over the week, remained 0.8% lower from its level at the beginning of this year, after a sharp rise of 75% rate of return attained in 2009.
The TA-75 index dropped 1.2% this week, remained 5% higher from its level at the beginning of the year, after total increase of 150% in 2009.
Shares of the major banks rose 0.5%. The Tel-Tech index of technology companies remained unchanged while the shares of large real estate companies dropped 1%.
"INTEC PHARMA", a drug development company, completed her first IPO this week and joins the 39 biomed companies already traded on TASE.
The total market value of all biomed companies comes to approximately US$2.4 billion and the value of the free float comes to approximately US$1.1 billion.
The Israeli treasury raised US $310 million this week in a local government bond issue, bringing the 2010 total to US $1.9 billion.
According to the Israel Tax Authority the state tax revenues in January 2010 increased by 10% compared with January 2009 due to the economic improvement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
